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Abstract
Background: The response of lung microvascular endothelial cells (ECs) to lipopolysaccharide (LPS) is central to
the pathogenesis of lung injury. It is dual in nature, with one facet that is pro-inflammatory and another that is
cyto-protective. In previous work, overexpression of the anti-apoptotic Bcl-XL rescued ECs from apoptosis triggered
by siRNA knockdown of intersectin-1s (ITSN-1s), a pro-survival protein crucial for ECs function. Here we further
characterized the cyto-protective EC response to LPS and pro-inflammatory dysfunction.
Methods and Results: Electron microscopy (EM) analyses of LPS-exposed ECs revealed an activated/dysfunctional
phenotype, while a biotin assay for caveolae internalization followed by biochemical quantification indicated that
LPS causes a 40% inhibition in biotin uptake compared to controls. Quantitative PCR and Western blotting were
used to evaluate the mRNA and protein expression, respectively, for several regulatory proteins of intrinsic
apoptosis, including ITSN-1s. The decrease in ITSN-1s mRNA and protein expression were countered by Bcl-XL and
survivin upregulation, as well as Bim downregulation, events thought to protect ECs from impending apoptosis.
Absence of apoptosis was confirmed by TUNEL and lack of cytochrome c (cyt c) efflux from mitochondria.
Moreover, LPS exposure caused induction and activation of inducible nitric oxide synthase (iNOS) and a
mitochondrial variant (mtNOS), as well as augmented mitochondrial NO production as measured by an oxidation
oxyhemoglobin (oxyHb) assay applied on mitochondrial-enriched fractions prepared from LPS-exposed ECs.
Interestingly, expression of myc-ITSN-1s rescued caveolae endocytosis and reversed induction of iNOS expression.
Conclusion: Our results suggest that ITSN-1s deficiency is relevant for the pro-inflammatory ECs dysfunction
induced by LPS.
Background
Severe sepsis is the leading clinical cause of lung injury
[1]. No specific therapy currently exists for this critical
illness, and efforts to reduce its burden have been lim-
ited by an incomplete understanding of the mechanisms
of disease. Exposure of ECs to LPS is a widely used
model for studying endothelial dysfunction in this syn-
drome [2]. The endothelial response to LPS is dual in
nature, with one facet that is pro-inflammatory and
another that is cyto-protective [2,3]. NF-Ba n dJ N K -
mediated pathways engage ECs to actively participate
and regulate the pro-inflammatory process in response
to LPS by expression and release of damaging
components such as iNOS, cytokines, adhesion mole-
cules, and pro-coagulants [4-6]. This response has been
alternatively referred to as the activated endothelial phe-
notype [4,5]. Much less is known however, with respect
to the exact nature, regulation and timing of the cyto-
protective aspect of the ECs response. A role of Bcl
members Bcl-2 and Bcl-XL in potentially shielding the
cells from their proapoptotic environment has been
described [2,3]. In our previous work, overexpression of
Bcl-XL rescued lung ECs from apoptosis after siRNA-
mediated knockdown of ITSN-1s, a novel scaffold and
regulator of the general endocytic machinery, as well as
a critical protein for pro-survival signaling in ECs [7,8].
ITSN-1s deficiency caused severe EC dysfunction,
decrease in caveolae number, structural alterations and
dysfunction of mitochondria, generation of mitochon-
drial reactive oxygen species (ROS) and apoptosis [7].
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previous studies of LPS-induced endothelial dysfunction
and the suggested role of Bcl-XL in cyto-protection dur-
ing inflammatory stress led us to consider ITSN-1s as a
participant in either of these events.
Numerous lines of evidence have documented the
considerable oxidative and nitrosative stress associated
with lung injury in human patients, and potential path-
ways by which either may mediate endothelial barrier
dysfunction have also been well described [9,10]. iNOS
is known to be up-regulated in response to LPS in a
variety of cells, including lung ECs [11]. The resultant
increased NO production has the ability to potentially
alter a large variety of cellular processes such as inter-
endothelial junctional integrity and thereby, basal vas-
cular permeability [9]. The selective inhibition of iNOS
has significantly attenuated the ability of endotoxin to
generate lung injury in several animal models [12,13].
Notably, loss of caveolin-1 (cav-1) expression and thus
lack of caveolae endocytosis and transcytosis resulted
in constitutive activation of eNOS, increased NO pro-
duction and a microvascular hyperpermeability cav-1
-/- mouse phenotype [14]. Thus, in the current study,
we sought to further characterize ECs dysfunction and
the elements of the cyto-protective ECs response to
LPS.
Methods
Cell lines and reagents
Human lung microvascular ECs were purchased from
Lonza (Walkersville, Inc., MD). LPS from Escherichia
coli 011:B4, calmodulin from bovine testes, tetrahydro-
biopterin (BH4), protease inhibitors cocktail, L-arginine
and primers for qPCR were from Sigma-Aldrich (St.
Louis, MO). Superoxide dismutase (SOD) from bovine
erythrocytes was purchased from MP Biomedicals.
Freeze dried Hb was from ICN Biomedicals. The
In Situ Cell Death Detection Kit, Fluorescein was from
Roche (Indianapolis, IN). Prolong Antifade Kit and neu-
trAvidin Alexa Fluor 594 were from Molecular Probes
(Eugene, OR). EZ-Link Sulfo NHS-SS-Biotin was from
Fisher Scientific (Hanover Park, IL). Streptavidin-HRP
conjugated, MicroBCA (bicinchoninic acid) Protein
Assay Reagent and Enhanced Chemiluminescent (ECL)
Western Blotting Substrate were from Pierce (Rockford,
IL). Specific antibodies (Abs) were obtained from the
following sources: anti-Bcl-XL mAb, anti-NOS2 pAb
from Santa Cruz Biotechnology (Santa Cruz, CA); anti-
cyt c mAb from Calbiochem; anti-ITSN-1s mAb from
BD Biosciences (San Jose, CA); anti-Bim pAbs from
Millipore (Billerica, MA); anti-survivin pAbs from
Novus Biologicals; Horseradish peroxidase (HRP)-conju-
gated reporters were from Cappel, Organon Teknika
(Durham, NC).
Endothelial Cell Culture and LPS treatment
ECs were cultured at 37°C in 5% CO2 in endothelial
growth medium-2 obtained from Lonza and prepared
according to manufacturer’s instructions. Cells between
the third and fifth passages were used for experiments.
LPS (dry powder) was reconstituted in growth medium
and applied over cells in a concentration of 1 μg/ml for
a duration of up to 48 hours.
Protein Extraction and Western blotting
Control ECs or cells exposed to 1 μg/ml LPS in culture
media were collected from culture dishes and washed
with PBS. Cell pellets were lysed for 1 h at 4°C in 50
mM Tris HCl, pH 8.0, 150 mM NaCl, 1% NP-40, and
protease inhibitors. For detection of phospho-Bim
(Ser
69) levels, control and LPS-treated ECs were solubi-
lized in kinase buffer (20 mM Tris/HCl, pH 7.4, 150
mM NaCl, 0.1% Nonidet P-40, 1% glycerol, 0.2 mM
sodium vanadate, 0.83 mM benzamidine, 0.23 mM phe-
nylmethylsulfonyl fluoride, 0.5 μg/ml aprotinin, and 0.5
μg/ml leupeptin). After centrifugation at 45000 rpm for
45 min at 4°C, the supernatants were collected and pro-
tein concentration determined by BCA with a bovine
serum albumin standard. Equivalent protein amounts
were subjected to SDS-PAGE and transferred to nitro-
cellulose membranes. The membranes were probed with
anti-NOS2 pAb, anti-Bcl-XL mAb, anti-ITSN-1 mAb,
anti-Bim pAb, anti-survivin pAb, diluted in blocking
buffer, (5% milk/TBS). Immunoreactive bands were
visualized with the appropriate HRP-conjugated Abs
and ECL detection. Densitometry was performed with
ImageJ v1.37 software.
Internalization Assay
Control and LPS-treated ECs, grown on plastic Petri
dishes or coverslips were washed with ice-cold PBS and
then incubated with 0.5 mg/ml cleavable biotin reagent
as in [15,16]. Biotinylated cell surface proteins were
internalized for 30 min, at 37°C. Biotinylated proteins
still at the cell surface after 30 min were reduced with
glutathione and the cells were further processed for
morphological analysis or lysed for biochemical investi-
gation. For biochemical studies, cells were lysed in TBS
containing 2% Triton X-100, and the lysates were clari-
fied by centrifugation for 30 min, at 4°C, 40,000 rpm in
a TLA-45 Beckman rotor, to obtain a final supernatant
expected to contain the internalized biotinylated pro-
teins. The number of biotin molecules in the ECs lysates
were quantified by ELISA as in [15]. Standard curves
were generated using known concentrations of albumin-
biotin. The average number of biotin molecules present
in each cell lysate was determined at a series of decreas-
ing concentrations from the linear part of the curve
obtained by successively diluting a standard volume
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protein. To obviate any interference between the bioti-
nylated proteins internalized via caveolae and biotin pre-
sent in mitochondria [17], we evaluated the biotin
content of mitochondria by ELISA applied on lysate pre-
pared from control ECs, not subjected to biotinylation
of cell surface proteins. Mitochondrial proteins comprise
only 0.25 × 10
14 biotin molecule/mg total protein, a
value without statistical significance, when compared to
the extent of biotin internalization via caveolae.
Measurement of Transendothelial Electrical Resistance
and paracellular permeability
ECs were grown to confluence on gold electrode array
plates available from Applied Biophysics, Inc., Troy, NY.
Transendothelial electrical resistance (TER) was mea-
sured by an electrical cell-substrate impedance sensing
system (Applied Biophysics, Inc.) as described in [18].
Briefly, the gold electrode plates were connected to a
phase-sensitive lock-in amplifier and a 1 volt 4000 Hz
AC signal was applied through a 1 MΩ resistor. In-
phase voltage was measured and used to determine TER
which was normalized to initial values. A decrease in
TER during the experiment reflects loss of cell-cell
adhesion.
Transwell assay
Transwell chambers with .4 μm pore filter inserts (BD
Bioscience) were used. The inserts were coated over-
night with 0.1% gelatin, at 37°C. Cells were seeded in
the upper compartment and grown for additional 3 days
post-confluency. Then, cell monolayers were subjected
to 1 μg/ml LPS for 6 h, as an early time point, and 48 h,
the time point used for biotin assay for caveolae interna-
lization. The last hour of LPS treatment, 1 mg/ml dini-
trophenylated (DNP)-BSA was added in the upper
chamber. To quantify the transport, 500 μlm e d i u m
from the lower chamber were removed and subjected to
ELISA, via anti-DNP Ab, as previously described [19,20].
All measurements were performed in triplicate and
repeated three times. A standard curve was generated by
diluting known concentration of DNP-BSA.
Molecular cloning of ITSN-1s expression construct
The full-length human ITSN-1s cDNA fragment (3,660
bp) was generated by PCR amplification from ITSN-1s
c D N A( g i f tf r o mS u z a n al aL una, Center for Genomic
Regulation, UPF, and Centro de Investigacion Biomedica
en Red de Enfermedades Raras, Barcelona, Spain) with
high-fidelity PCR enzyme (New England Biolabs), using
the following primer pair: ITSN1s_F269-BstBI:5 ’
AGTA TTCGAA CC ATG GCT CAG TTT CCA ACA
CCT T 3’and ITSN1s_R3929-NheI:5 ’ CGTA GCTAGC
TTG CTG GCT TGG GTC CAT GTC TG 3’. The PCR
products of the full-length ITSN-1s were digested with
restriction enzyme BstBI and Nhe I (New England Bio-
labs) and purified (Qiagen purification kit), then cloned
into a expression vector, pReiver-M10a (GeneCopoeia)
at BstBI-NheI sites using T4 ligase (New England Bio-
labs). The ligation products were transformed into E.
coli strain Top10 (Invitrogen). Dozens of transforming
colonies were selected and subjected to PCR to identify
the colonies with the ITSN-1s inserts using the same
sequencing primer pair. The plasmid DNA was
extracted from 6 selected growing clones bearing the
ITSN-1s insert and was verified with correct restriction
enzyme (BstBI and Nhe I) sites. Finally, one of them,
CS-Z3999_ITSN1s #16 was selected for maxi-prepara-
tion of plasmid DNA, sequencing confirmation of the
entire integrity of the full-length cDNA of ITSN-1s in
frame in the vector and used for transfection of ECs. All
transfections were performed using FuGENE 6, accord-
ing to the manufacturer’s instructions.
Mitochondrial isolation and measurement of iNOS activity
Preparation of Mitochondrial fractions
EC monolayers grown on Petri dishes were washed
three times with ice-cold PBS, pH 7.4, and collected by
gentle scraping and centrifugation at 500 × g for 10
min. The cell pellets were resuspended in isolation buf-
fer containing 250 mM sucrose, 40 mM Tris/HCl, pH
7.5, 10 mM MgCl2, 2 mM CaCl2, 1 mM phenylmethyl-
sulfonyl fluoride, 15 μg/ml leupeptin as in [7]. They
were kept on ice for 30 min and then disrupted with 40
s t r o k e si nag l a s sD o u n c eh o m o g e n i z e r .T h i sw a sf o l -
lowed by centrifugation at 800 × g at 4°C for 10 minutes
to remove unbroken cells, nuclei, and debris. The post-
nuclear supernatant was then subjected to centrifugation
at 22,000 × g at 4°C for 10 minutes to isolate the mito-
chondrial pellet. The mitochondrial pellet was lysed in
50 mM HEPES, pH 7.4, 1% Nonidet P-40, 10% glycerol,
1 mM EDTA, 2 mM dithiothreitol, and protease
inhibitors.
Spectrophotometric determination of iNOS activity
NO production was assayed by utilizing its reaction
with oxyHb to produce the optically distinct methemo-
globin (metHb) as previously described [21]. Briefly,
unlysed mitochondrial pellets were resuspended in
hypo-osmotic solution by adding 2 volumes of ice-
chilled water containing a protease inhibitor cocktail.
This was followed by sonication at 100 W, 50% duty
cycle, and 75 s. Isolation buffer of twice the concentra-
tion used for the preparation of mitochondrial frac-
tions was then added in the same amount as water
used in the previous step. The suspension was centri-
fuged at 10,000 × g at 4°C for 10 min. The supernatant
contained broken mitochondria and was used for the
subsequent reaction.
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oxyHb and metHb which must be fully reduced to
obtain pure oxyHb for the reaction. This was accom-
plished by the Dixon and McIntosh method [22]. Briefly,
0.2 ml of 0.1 g/ml sodium dithionite was added to a
prepacked Sephadex column. When all of the dithionite
had completely entered the gel bed, 1 ml of 50 mg/ml
Hb was added. As the Hb passed through the dithionite
zone, its color changed to purple and it then changed to
an orange-red color as it left the dithionite. This was
collected and the concentration measured spectrophoto-
metrically using ε415 nm 131.0 mM
-1cm
-1.
Dilution or oxidation of NOS substrates or cofactors
during the preparation of broken mitochondria requires
the presence of 5 μg/ml calmodulin, 50 μM L-arginine,
10 μM tetrahydrobiopterin (BH4), and 1 KU/ml SOD in
the assay medium. These substrates were added to 1 mL
of 100 mM HEPES, pH 7.1 in a cuvette followed by 4
μMo x y H b .3 0μg of mitochondrial protein was added
and the optical density continuously recorded for five
minutes at a wavelength of 401 nm. NO formation was
quantified using ε401(metHb-oxyHb) of 49 mM
-1cm
-1.
Terminal Deoxynucleotidyltransferase-mediated dUTP
Nick End Labeling (TUNEL) Assay
Control ECs and cells exposed to LPS (1 μg/ml) for up
to 48 h were washed in PBS and then fixed and permea-
bilized in methanol for 7 min, at -20°C. The TUNEL
reaction mixtures (label and enzyme solutions) were
prepared as directed by the manufacturer. It was applied
over EC monolayers for 60 min, at 37°C, under dark
and humid conditions. Monolayers exposed to label
solution only were used as negative controls. The cells
were washed and coverslips mounted using the Prolong
Antifade kit. Fluorescence microscopy with an excitation
wavelength of 488 nm identified TUNEL-positive cells.
qPCR studies
Cells were lysed using the Qiagen QIAShredder homo-
genizer and the RNA was isolated using the Qiagen
RNeasy Mini RNA isolation kit as per the manufac-
turer’s instructions. cDNA was generated with the high-
capacity cDNA RT kit by Applied Biosystems following
the manufacturer’s protocol. Amplifications were carried
out using the following primers: ITSN-1s (5’-
CAGGCTTGAAAGTCCTCAAAG-3’,5 ’-GGTGAT-
CATGCTGGAAGTCA-3’), Bim (5’-TCCCTGCTGT
CTCGATCCTC-3’,5 ’-GGTCTTCGGCTGCTTGGTAA-
3’), Bcl-XL (5’-CTGTCGGTGGAAAGCGTAGA-3’,5 ’-
TGCTGCATTGTTCCCATAGAG-3’), Survivin (5’-
AAGAACTGGCCCTTCTT GGA-3’,5 ’-CAACCGGAC-
GAATGCTTTT-3’). mRNA levels were quantified by
real-time monitoring of the products of the cDNAs PCR
with SYBR Green fluorescent dye. Cyclophilin was used
as internal control.
Electron microscopy
Control and LPS-treated cells were subjected to stan-
dard EM procedure [15]. Briefly, EC monolayers were
fixed in 1.5% glutaraldehyde in 0.1 M sodium cacodylate
buffer, pH 7.4, containing 5% sucrose for 30 min at RT.
After washing in the same buffer the cells were post-
fixed in Palade’s1 %o s m i u mt e t r o x i d ef o r1ho ni c e ,
stained with Kellenberger buffer, dehydrated in graded
ethanol, and embedded in Epon at 60°C.
Results and discussion
LPS exposure causes an activated/dysfunctional ECs
phenotype
It is well documented that ECs are active participants in
and regulators of inflammatory processes such as severe
bacterial infection [4,23]. However, there is still significant
debate on the extent of vascular dysfunction that is due to
the direct effects of bacterial products such as LPS on the
endothelium. Thus, in this study we evaluated by high-
resolution EM the morphological changes caused by direct
LPS exposure on human lung microvascular ECs. Conflu-
ent ECs monolayers were treated with 1 μg LPS/ml, for 48
h, and then subjected to standard EM procedure as in [7].
Detailed examination revealed disrupted interendothelial
junctions (IEJs), as illustrated in Figure 1a, b, and increased
accumulation of actin filaments at cell periphery (Figure
1c arrows), suggesting increased paracellular permeability,
one of the first sign of endothelial activation in response
to inflammation. Several cellular organelles such as Wei-
bel-Palade bodies and Golgi show apparently normal mor-
phology, but their number was significantly increased
(Figure 1d, f, f1) by reference to control ECs. Golgi orga-
nelles were spread throughout the cell, while a swollen
endoplasmic reticulum (Figure 1c), occupied the entire
intracellular space, observations consistent with expression
of pro-inflammatory/cytoprotective genes as well as the
ER stress. Fragments of control ECs are shown for com-
parison, (Figure 2a, a1). Note that these cells maintain in
culture their endothelial phenotype; in close proximity of
the nucleus there are Golgi stacks and vesicles as well as
two mitochondrial units showing well-organized cristae. A
normal, unswollen endoplasmic reticulum is detected
within the two mitochondrial units. Note also a Weibel-
Palade body by the basolateral plasma membrane. Caveo-
lae, the main vesicular carriers of ECs, involved in the
transport of plasma proteins and nutrients across the
endothelium are open apically or basolaterally, apparently
charging or discharging their load, (Figure 2a1 arrows). In
LPS-treated ECs we have also frequently noted numerous
small mitochondrial units. Large vacuoles, increased
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Page 4 of 14Figure 1 LPS exposure causes an activated/dysfunctional ECs phenotype (I). ECs exposed to 1 μg/ml LPS for 48 h show open IEJs, (a, b),
increased accumulation of actin filaments at cell periphery (c, arrows), significant increase in the number of Weibel-Palade (wp) bodies (d) and
Golgi (f, circled areas). An enlarged and widespread endoplasmic reticulum network and the presence of a dilated tubular system are shown in
e; frequently, increase number of lysosomal (lys) units is observed (a, d, f). Panel g shows a segment of cultured lung microvascular ECs
comprising increased number of mitochondrial units (m), most of them with abnormal morphology. Note also the close association between ER
and mitochondria. Frequently, mitochondria undergo a fission process (g1). Bars: 100 nm (a, b, d, e, f, g); 50 nm (c);
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(Figure 2b) some of them opened to the apical front of the
cell (Figure 2c, d) are detected, suggesting impaired endo-
cytosis and activation of alternative, non-conventional,
transport pathways [24]. Altogether, these observations are
consistent with an activated and dysfunctional EC
phenotype.
Endocytic dysfunction and a concomitant paracellular
hyperpermeability is a hallmark of the LPS-EC phenoytpe
Since LPS signaling is regulated by caveolae endocytosis
[25,26] and since EM analysis revealed endocytic
abnormalities in LPS-treated cells, we next used a biotin
internalization assay as in [15,16] to address if EC expo-
sure to LPS affects caveolae endocytosis. This assay is a
specific and reliable approach for addressing caveolae
internalization in cultured ECs [15]. Caveolae-mediated
uptake of biotinylated cell surface proteins is the domi-
nant mechanism of internalization in ECs; the number
of clathrin-coated vesicles in ECs is relatively small and
their contribution to the internalization process is minor
[27]. Briefly, control and LPS-exposed ECs were sub-
jected to biotinylation of cell surface proteins, at 4°C,
using a cleavable biotin reagent. Then, cells were
Figure 2 LPS exposure causes an activated/dysfunctional ECs phenotype (II). Fragments of control ECs show a normal endothelial
phenotype: Golgi stacks and vesicles as well as two mitochondrial units with well-organized cristae (a), a wide endoplasmic reticulum network is
located within the two mitochondrial units. Note also a Weibel-Palade (wp) body in close proximity of the basolateral plasma membrane.
Caveolae are open apically or basolaterally, apparently charging or discharging their load, (a1, arrows). In panel b, a fragment of an ECs
subjected to 1 μg/ml LPS shows frequently large vacuoles (v1, v2), membranous rings, (arrows) and tubules (t), within cytosol or open to the
cell surface (c, d), suggestive of deficient endocytic transport. Bars: 50 nm (a); 100 nm (a1); 70 nm (b); 40 nm (c, d).
Singla et al. Respiratory Research 2011, 12:46
http://respiratory-research.com/content/12/1/46
Page 6 of 14transferred to 37°C, for 30 min, to allow internalization
of biotinylated proteins. The biotinylated proteins, still
on the cell surface after 30 min were reduced with glu-
tathione. Then, the cells were either lysed for biochem-
ical quantification of LPS effects on caveolae
internalization by enzyme-linked immunosorbent assay
(ELISA) or subjected to neutrAvidin-Alexa Fluor 594
staining for morphological surveys by fluorescence
microscopy. Biochemical quantification of the number
of biotin molecules internalized by control and LPS-
exposed cells, Figure 3A indicated that in LPS-treated
EC lysates, the number of biotin molecules was consid-
erably smaller. A comparison of LPS-treated cells to
controls shows an inhibition of 40%, (Figure 3B). Mor-
phological analyses with NeutrAvidin-Alexa Fluor 594
revealed in control cells a fine punctate pattern through-
out the cytoplasm, suggestive of vesicular association,
(Figure 4c1). Frequently, biotin accumulation in the
perinuclear area was detected. In LPS-exposed cells the
staining was limited (Figure 4c2); large fluorescent
puncta within the cytosol and no biotin accumulation in
the perinuclear area were observed, suggestive of
impaired biotin internalization. The intercellular spaces
are large, consistent with disruption of IEJs. Highly mag-
nified controlled and LPS-exposed cells (boxed areas),
are shown, (Figure 4c1.1, c2.1).
Since 1 μg/ml LPS exposure downregulates ITSN-1s
expression and as a result transcellular transport is
impaired, we next evaluated the status of paracellular
permeability of ECs monolayers by measurements of
TER, under the same conditions of LPS exposure.
Monolayers of ECs grown on gold microlectrodes, three
days post-confluency, were first stabilized for two hours
to establish a linear TER baseline. Then, The stabilized
monolayers were stimulated with LPS (Figure 5A,
arrow) and TER was monitored over 24 hours, Figure
5A. A gradual decrease in the baseline barrier resistance
was recorded for the first hours after LPS stimulation
with a maximal decrease after 8 h and remaining in a
plateau for the next 16 h hours. These data strongly
suggest that LPS disrupts endothelial barrier and signifi-
cantly increases the paracellular permeability of lung
microvascular ECs. To get more insights on the extent
of endothelial barrier dysfunction, we quantified the
paracellular transport of dinitrophenylated albumin
(DNP-BSA) using a transwell assay, as described under
Methods. In brief, cells were seeded in the upper cham-
ber and 3 days post-confluency, endothelial monolayers
were subjected to 1 μg/ml LPS for 6 h, as an early time
point, and 48 h, the time point used for biotin assay for
caveolae internalization. In the last hour of LPS treat-
ment, BSA-DNP was layered on top of EC monolayers
to a final concentration of 1 mg/ml. To quantify the
transport, 500 μl medium from the lower chamber were
removed and subjected to ELISA, via DNP Ab, as pre-
viously described [19,20]. As shown in Figure 5B, the
permeability of the endothelial monolayer for the DNP-
BSA tracer were determined at a series of decreasing
equivalent mg total protein/well
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Figure 3 Effects of 1 μg/ml LPS exposure causes significant inhibition of caveolae internalization. A. Control and LPS-treated cells were
subjected to biotinylation of cell surface proteins as described under Materials and Methods, followed by internalization of biotinylated proteins
for 30 min, at 37°C. The number of biotin molecules present in lysates of control and LPS-treated cells was quantified by ELISA using
streptavidin-HRP Ab, in 3 different experiments. The results were normalized per milligram total protein, per 30 min. Ordinate, amounts of biotin
molecules/well detected per well; abscissa, μg total protein/well as result of serial dilution of control and LPS-treated ECs lysates. B. Degree of
inhibition of caveolae-mediated uptake in LPS-treated ECs by reference to controls. Bars, ±SE.
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by serial dilution of a standard volume of growth media
removed from the lower chamber. In the presence of
LPS, the amounts of DNP-BSA crossing the monolayer
were considerably higher than control levels. Measure-
ments of DNP-BSA amounts, using a series of concen-
trations on the straight part of the curve, indicated that
at 6 hours after LPS exposure, the lower chamber con-
tains 118.10 ± 7.3 ng DNP-BSA/100 μl medium, while
at 48 h, 164.63 ± 12.4 ng DNP-BSA/100 μl medium, sig-
nificant increase over the control levels estimated at 10.1
± 0.9 ng DNP-BSA/100 μlm e d i u m ,F i g u r e5 C .T h e
findings are consistent with endothelial barrier dysfunc-
tion, gap formation and DNP-BSA leakage, as result of
LPS exposure.
Induction and activation of iNOS and a mitochondrial
variant by LPS exposure
Expression iNOS in response to LPS has been reported
for several cell types such as epithelial cells, fibroblasts,
hepatocytes, ECs [28,29]. A mitochondrial NOS,
mtNOS, constitutively expressed, continuously active
and associated with the inner mitochondrial membrane
has been reported [21,30]. LPS-induced up-regulation of
mitochondrial NO is one of the specific means, however
still enigmatic, by which a dysfunctional and potentially
pro-apoptotic environment is generated during the pro-
inflammatory response in many cell types [31-33]. Thus,
to evaluate the expression of iNOS and mtNOS in LPS-
exposed human lung microvascular ECs, we first investi-
gated by immunoblotting the expression of iNOS in
control and LPS-treated ECs (Figure 6A). We detected
weak iNOS immuno-reactivity under control conditions,
and it increases by 27%, at 24 h and by 75% at 48 hours
post LPS exposure (Figure 6B). Next, we investigated
the effects of LPS on mtNOS expression. To this intent,
mitochondria-enriched fractions prepared from these
cells were lysed and subjected to SDS-PAGE. Even if
mtNOS is constitutively expressed, the levels seem to be
low, since no iNOS immunoreactivity was detected in
Figure 4 NeutrAvidin Alexa Fluor 594 staining demonstrates inhibition of caveolae internalization by 1 μg/ml LPS exposure.
NeutrAvidin Alexa Fluor 594 staining of control ECs subjected to biotinylation of cell surface proteins followed by internalization assay, indicates
a strong punctate pattern throughout the cytosol (c), with some accumulation in the perinuclear area. An enlarged ECs (boxed area in c)
subjected to the internalization assay is shown in c1. ECs exposed to LPS and subjected to the internalization assay followed by neutrAvidin
Alexa Fluor 594 staining (b, b1) show large fluorescent puncta within the intracellular space with no perinuclear accumulation. Bars: a, a1, b, b1 -
20 μm.
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Page 8 of 14the absence of LPS and under experimental conditions
used (Figure 6C). However, in the mitochondrial frac-
tion prepared from LPS-exposed ECs, mtNOS protein
expression is easily detected, at 48 hours of LPS expo-
sure (Figure 6C). Next, we addressed if the increased
expression of mtNOS resulted in increased NO produc-
tion. mtNOS activity was assessed by exposing freshly
prepared, unlysed mitochondrial fractions from ECs to
oxyHb, as described under Methods. The rate of NO
production was measured by the change in optical den-
sity of the reaction mixture as generated NO quickly
oxidized oxyHb to metHb. As shown in Figure 6D,
mitochondria from LPS-treated ECs exhibited a two-fold
greater rate of NO formation than untreated controls
(0.81 nmol/min mg total protein versus 0.40 nmol/min
mg total protein).
ITSN-1s protein and mRNA levels are markedly decreased
after LPS exposure
We have recently shown that specific and efficient
ITSN-1s knockdown via a specific siRNA duplex tar-
geting ITSN-1 gene results in severe EC dysfunction
and apoptotic death, events that can be reversed by
overexpression of the anti-apoptotic Bcl-XL[7].
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microelectrodes, were exposed to 1 μg/ml LPS, and TER was monitored over time. Data are expressed as means ± SD of 3 independent
experiments; n = 3 per condition for each experiment. DNP-BSA concentrations detected in growth media collected from the lower chamber in
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Page 9 of 14Previous studies of LPS-induced endothelial dysfunc-
tion suggested the ability of LPS to induce pro-apopto-
tic pathways [34] as well as a role of Bcl-XL in cyto-
protection during inflammatory stress [3]. These obser-
vations led us to consider ITSN-1s as a participant in
either of these events. We therefore evaluated the
levels of ITSN-1s protein in lysates prepared from
LPS-treated and control ECs by immunoblotting with
ITSN-1 pAb. The 140 kDa band representing ITSN-1s
begins to decrease in intensity at 24 h and remains sig-
nificantly decreased at 48 h after LPS exposure (Figure
7A). We also evaluated the level of ITSN-1s mRNA
expression by quantitative PCR in ECs exposed to 1
μg/ml LPS for 24 or 48 hours. ITSN-1s mRNA levels
were dramatically reduced in LPS-exposed ECs com-
pared to control cells (Figure 7B). ITSN-1s mRNA
expression was reduced 4.3-fold at 24 hours and 3.2-
fold at 48 hours of LPS treatment compared to
untreated controls. These results are consistent with
the idea that LPS down-regulates the expression of the
pro-survival protein ITSN-1s; ITSN-1s deficiency may
be relevant to ECs dysfunction induced by LPS.
Lung ECs do not undergo apoptosis in response to LPS
Since LPS-exposed ECs show decreased mRNA levels
for ITSN-1s and since ITSN-1s deficiency is expected to
initiate intrinsic apoptosis, we evaluated the occurrence
of apoptosis in cells treated with LPS for 48 h, by
TUNEL, Figure 7C, c1. Morphological surveys and mor-
phometric analyzes show that the number of TUNEL-
positive ECs is extremely low, comparable to untreated
ECs (Figure 7D). A positive control, in which cells were
subjected to ITSN-1s knockdown by siRNA as in our
previous work [7], is shown in Figure 7C, c2. A comple-
mentary strategy to evaluate if mitochondrial cell death
occurred was the examination of cyt c efflux from mito-
chondria. An enriched-mitochondrial fraction and the
post-mitochondrial supernatant prepared from LPS-trea-
ted ECs normalized for total protein content were sub-
jected to SDS-PAGE and Western blot with cyt c mAb.
No immunoreactivity for cyt c was detected in the post-
mitochondrial supernatant, consistent with cyt c con-
finement to mitochondria (Figure 7E). The findings sug-
gest that ITSN-1s down-regulation as caused by LPS
exposure of ECs did not trigger the intrinsic apoptotic
pathway and suggest that LPS induces a cyto-protective
response.
LPS directly induces Bcl-XL and survivin expression, as
well as down-regulation of the “BH3 only” Bim
expression
T h ep r o t e c t i v ee f f e c t so fB c l - X L overexpression against
LPS and ITSN-1s deficiency-induced cell death were
previously documented [3,7]. However, whether LPS
c a nd i r e c t l yi n d u c eB c l - X L expression has not been
reported for human lung microvascular ECs. To deter-
mine whether LPS up-regulates the mRNA for Bcl-XL,
ECs were exposed to LPS for different time points (24
h, 48 h), and the levels of Bcl-XL protein and mRNA
were determined (Figure 8). At 24 h, the levels of Bcl-
XL are increased by 1.3-fold, while at 48 h a signifi-
cant, 3.4 fold-increase, compared to controls is
detected. Thus, LPS can up-regulate the mRNA for
this cyto-protective protein. Levels of Bcl-XL protein
correspond to mRNA accumulation. Interestingly, ECs
deficient in ITSN-1s show decreased Erk1/2 activation
[7]. Erk1/2 activation is responsible for constitutive
phosphorylation of the pro-apoptotic “BH3 only” pro-
tein Bim, at Ser
69 leading to proteasomal degradation
[35-37]. Thus, it is possible that down-regulation of
Bim may be another possible mechanism by which ECs
cyto-protection occurs in response to LPS. To deter-
mine whether LPS affects the levels of phospho-Bim
(Ser
69), control and LPS-treated ECs were solubilized
in kinase buffer; equal amounts of total protein were
subjected to SDS-PAGE and Western blot with a spe-
cific phospho-Bim (Ser
69) Ab. Total Bim was detected
Figure 6 Induction of iNOS and its mitochondrial variant
expression by LPS exposure. Total cell lysates (70 μg/lane) of
control and LPS-treated ECs (24 h and 48 h) were subjected to SDS-
PAGE, electrotransfer and immunoblotting with NOS2 Ab, known to
recognize the iNOS and mtNOS [31]. A representative blot,
documenting the increased expression of iNOS caused by LPS is
shown in (A). Blots obtained from 3 different experiments
performed under identical experimental conditions (70 μg total
protein/lane, 1:1000 NOS2 pAb dilution and 30 sec ECL exposure
time) were subjected to densitometric analysis (B), Bars, ±SE C.
Control and LPS-treated ECs were subjected to cell fractionation to
obtain an enriched-mitochondrial fraction; mitochondria were then
lysed and analyzed by SDS-PAGE and Western blot using NOS2 Ab.
D. mtNOS activity was assessed by exposing freshly prepared,
unlysed mitochondrial fractions of control and LPS-treated ECs to
oxyHb assay. The rate of NO production was measured by the
change in optical density of the reaction solution as generated NO
quickly oxidized oxyHb to metHb. The bar graph shows the
difference in rate of mitochondrial NO formation between control
and LPS-treated ECs.
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Page 10 of 14with a specific anti-Bim pAb (Figure 8). Substantial
decrease in both P-Bim (Ser
69) and total Bim was
noted. Next, qPCR for mRNA levels were performed;
in response to LPS exposure, Bim mRNA was dramati-
cally reduced, 11-fold compared to untreated controls
at 24 hours and recovered to 1.2-fold reduction at 48
hours (Figure 8). These studies are consistent with the
idea that down-regulation of Bim, as well as up-regula-
tion of Bcl-XL serve as cyto-protective pathways
against LPS-induced apoptosis in lung microvascular
ECs.
Since Bim down-regulation was linked to the overex-
pression of survivin, an inhibitor of apoptosis protein,
[38] and since LPS-induced NF-kB signaling may regu-
late survivin expression [39], we next examined by Wes-
tern blot and qPCR the effects of LPS on survivin
expression. As shown in Figure 8, survivin mRNA levels
increased 5.2-fold in the first 24 h and remained
increased by 4.2-fold at 48 h. The relative increase in
survivin protein levels was confirmed by Western blot
(Figure 8). The observation further documents that sur-
vivin up-regulation is another anti-apoptotic effect
induced by LPS in ECs.
Expression of myc-ITSN-1s in LPS-treated ECs restores
endocytosis and inhibits LPS signaling
Since cav-1 is a potential molecular chaperone that
directly inactivates all NOS isoforms [40], and since
ITSN-1s down-regulation inhibits caveolae internaliza-
tion and thereby, increases LPS signaling [25], we
sought to investigate if restoring endocytosis by ectopic
expression of myc-ITSN-1s can affect iNOS expression.
To this intent, subconfluent ECs monolayers, exposed to
LPS for 48 h, were transfected with myc tagged full-
length ITSN-1s, as previously described [15]. Efficient
ITSN-1s expression was detected at 48 h post-transfec-
tion by immunoblotting of ECs lysates with anti-myc
Ab, Figure 9C. Next, ECs grown on coverslips and
exposed to LPS for 48 h, were transfected with myc-
ITSN-1s and subjected to the biotin internalization
assay. Fluorescent microscopy analyses of internalized
biotin via neutrAvidin AlexaFluor 594 staining indicated
that most of the cells display a fine punctate pattern
staining (Figure 9A, a2, a3) similar to control cells (Fig-
ure 9A, a1), suggestive of biotin internalization via
caveolae. Biochemical quantification of biotin molecules
in lysate prepared from LPS-treated/ITSN-1s-transfected
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Figure 7 LPS-induces ITSN-1s deficiency without affecting the EC survival. Control and LPS-treated ECs lysates were analyzed by Western
blot (A) and qPCR (B) for ITSN-1s protein and mRNA expression. The ITSN-1s mRNA levels, relative to the internal control, cyclophilin, were
evaluated in three separate experiments. C. TUNEL staining of ECs treated with 1 μg/ml of LPS for 48 hours show no evidence for apoptotic
activity (c2). A positive control - siRNA ITSN-1s - transfected ECs is shown in c1. D. Quantitative assessment was obtained by counting the
number of TUNEL-positive and TUNEL-negative cells in 25 high-powered fields and calculating the percentage of apoptotic cells amongst the
total cell population. No significant difference was noted in the percentage of apoptotic cells between LPS-treated and control ECs (0.89% vs.
0.98%, p = .45). E. Mitochondrial fractions and post-mitochondrial supernatants prepared for LPS-treated cells were analyzed for cyt c reactivity.
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Page 11 of 14cells shows that these ECs significantly recovered their
ability to internalize biotin, when compared to untreated
cells (Figure 9B). Less than 25% inhibition of biotin
internalization, still detected after myc-ITSN-1s expres-
sion, can be explained by the incomplete transfection of
t h ee n t i r eE C sp o p u l a t i o n .F o rt h es a m er e a s o n ,e v a l u a -
tion of the effects of ITSN-1s rescue on paracellular per-
meability is methodologically limited.
To evaluate the effects of myc-ITSN-1s expression and
effective endocytosis on iNOS expression, we prepared
total cell lysates from control, LPS-treated and LPS-trea-
ted/ITSN-1s-transfected ECs; equivalents of total protein
amounts were analyzed by SDS-PAGE, electrotransfer to
nitrocellulose membranes and western blot using NOS2
Ab. LPS-treated/ITSN-1s-transfected ECs show lower
immunoreactivity to NOS-2 Ab and thereby, lower
expression of iNOS, by comparison to LPS-treated ECs
(no ITSN-1s transfection), Figure 9C. Then, the effects
of myc-ITSN-1s expression on mtNOS in LPS-exposed
ECs, were analyzed on mitochondrial-enriched fractions
prepared from control, LPS-treated and LPS-treated/
ITSN-1s-transfected ECs; mitochondrial lysates were
normalized for total protein content and analyzed by
SDS-PAGE, electrotransfer to nitrocellulose membranes
and western blot using NOS2 Ab. As shown in Figure
9D, mtNOS is detected in the mitochondria fraction
prepared from LPS-treated ECs. No NOS2 immunoreac-
tivity was detected in control or LPS-treated/ITSN-1s-
transfected ECs. The observation is consistent with the
idea that ITSN-1s deficiency and the resultant impaired
caveolae internalization is relevant to ECs response to
inflammatory stimuli.
Conclusions
Vascular barrier dysfunction contributes to the clinical
hallmark of lung injury [41]. Transport of plasma pro-
teins and solutes across the endothelium involves a
cross-talk between the transcellular route via caveolae
and the paracellular route through IEJs, [27,42]. In a
previous study, when caveolae transcytosis was disrupted
by cav-1 knockdown, the IEJs opened and a protein-rich
interstitial edema reminiscent of LPS-induced lung
injury developed [43]. Interestingly, treatment with the
NOS inhibitor, L-NAME, reversed the effects of cav-1
knockdown on junctional hyperpermeability.
Our current observations of LPS-induced ITSN-1s
down-regulation and subsequent endocytic traffic dys-
function and disruption of IEJs support the established
cross-link between the transcellular and paracellular
transport pathways and suggest a possible mechanism
by which NO mediates this coupling is via NOS-2 acti-
vation and its association with mitochondria.
Our data also show that during LPS-induced ITSN-1s
down-regulation, ECs do not undergo apoptosis as
occurs when these cells are depleted of ITSN-1s via a
specific siRNA duplex targeting ITSN-1s gene [7].
Furthermore, in our study we found that ECs may be
protected from apoptosis by the compensatory LPS-
mediated down-regulation of pro-apoptotic Bim and up-
regulation of anti-apoptotic Bcl-XL and survivin. These
observations are in line with previous studies indicating
that human ECs undergo apoptosis in response to LPS
only when protein synthesis is inhibited. Induced cyto-
protection maintains ECs in a state of activated dysfunc-
tion which may perpetuate their critical contribution to
the mechanisms of lung injury. Indeed, studies in animal
models and human patients with lung injury have
shown that apoptosis may be a prerequisite to the reso-
lution of inflammation and initiation of repair [44,45].
One of the keys to advancing recovery in lung injury
m a yt h e r e f o r el i ei nu n d e r s t a n d i n gt h et r a n s i t i o n
between the dysfunctional, cyto-protective phenotype
described here and the onset of programmed cell death.
Altogether, our studies established the role of the
endocytic protein, ITSN-1s, as a novel node in LPS-EC
signaling and offer interesting insights into the
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Figure 8 Control and LPS-treated cell lysates (24 h, 48 h) were
also analyzed by qPCR for mRNA expression of Bim, Bcl-XL and
survivin, relative to the internal control, cyclophilin, in three
separate experiments. Representative results of one of these
experiments are shown. Total protein concentration in control and
LPS-treated cell lysates was determined by BCA, and 80 μg of total
protein per sample was subjected to SDS-PAGE. Gels transferred to
nitrocellulose membranes were then probed with Bcl-XL, Bim and
survivin Abs. These trends were confirmed in at least three separate
experiments for each protein.
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production, cyto-protection, and the potential relation-
ships between these systems in ECs during LPS-induced
lung injury.
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